India, March 10 -- Alcon, the global leader in eye care, has announced the launch of Hydrus(R) Microstent in India. This minimally invasive glaucoma surgery (MIGS) device is designed to lower intraocular pressure (IOP) for patients with open-angle glaucoma in conjunction with cataract surgery.

MIGS are a lower risk intervention for glaucoma patients, enabling physicians to lower IOP with a reduced risk of complications compared to incisional filtration surgeries while allowing for rapid visual recovery, Hydrus' HORIZON trial is the first and only MIGS study to report 5-year clinical outcomes, with continuous follow up and 80% patient retention at year five (n=442/556).

Hydrus is also recognised by leading medical bodies and evidence rev...